1. Home
  2. THRD vs PKOH Comparison

THRD vs PKOH Comparison

Compare THRD & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • PKOH
  • Stock Information
  • Founded
  • THRD 2019
  • PKOH 1907
  • Country
  • THRD United States
  • PKOH United States
  • Employees
  • THRD N/A
  • PKOH N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • PKOH Industrial Specialties
  • Sector
  • THRD Health Care
  • PKOH Industrials
  • Exchange
  • THRD Nasdaq
  • PKOH Nasdaq
  • Market Cap
  • THRD 157.7M
  • PKOH 355.7M
  • IPO Year
  • THRD 2022
  • PKOH N/A
  • Fundamental
  • Price
  • THRD $3.45
  • PKOH $21.28
  • Analyst Decision
  • THRD Buy
  • PKOH
  • Analyst Count
  • THRD 3
  • PKOH 0
  • Target Price
  • THRD $14.00
  • PKOH N/A
  • AVG Volume (30 Days)
  • THRD 435.5K
  • PKOH 21.3K
  • Earning Date
  • THRD 03-25-2025
  • PKOH 03-05-2025
  • Dividend Yield
  • THRD N/A
  • PKOH 2.35%
  • EPS Growth
  • THRD N/A
  • PKOH 284.21
  • EPS
  • THRD N/A
  • PKOH 2.40
  • Revenue
  • THRD N/A
  • PKOH $1,656,200,000.00
  • Revenue This Year
  • THRD N/A
  • PKOH $7.84
  • Revenue Next Year
  • THRD N/A
  • PKOH $3.92
  • P/E Ratio
  • THRD N/A
  • PKOH $8.84
  • Revenue Growth
  • THRD N/A
  • PKOH N/A
  • 52 Week Low
  • THRD $3.18
  • PKOH $21.00
  • 52 Week High
  • THRD $16.94
  • PKOH $34.50
  • Technical
  • Relative Strength Index (RSI)
  • THRD 30.03
  • PKOH 31.35
  • Support Level
  • THRD $3.36
  • PKOH $22.43
  • Resistance Level
  • THRD $3.65
  • PKOH $24.21
  • Average True Range (ATR)
  • THRD 0.14
  • PKOH 0.96
  • MACD
  • THRD 0.16
  • PKOH -0.22
  • Stochastic Oscillator
  • THRD 35.48
  • PKOH 7.78

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives most of the revenue from the Supply Technologies segment which provides the customer with total supply management services such as engineering and design support, supplier selection, quality assurance, barcoding, product packaging and tracking, just-in-time and point-of-use delivery and electronic billing services for a range of production components.

Share on Social Networks: